J

Jiangsu Nanfang Medical Co Ltd
SSE:603880

Watchlist Manager
Jiangsu Nanfang Medical Co Ltd
SSE:603880
Watchlist
Price: 6.51 CNY 0.77% Market Closed
Market Cap: ¥1.9B

Relative Value

The Relative Value of one Jiangsu Nanfang Medical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 6.51 CNY, Jiangsu Nanfang Medical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Jiangsu Nanfang Medical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Jiangsu Nanfang Medical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jiangsu Nanfang Medical Co Ltd
SSE:603880
1.9B CNY 3.2 -9.3 -12.3 -12.3
JP
Hoya Corp
TSE:7741
8.6T JPY 9.6 40.9 25.3 30.3
CH
Alcon AG
SIX:ALC
30.8B CHF 3.9 37.7 19.7 38.4
US
Medline Inc
NASDAQ:MDLN
36.4B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
120.8B DKK 4.3 33.2 15.3 18.2
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD 3 32 14.5 18.4
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.7 29.7 17.9 29
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.2B CNY 9.5 26.3 23.6 23.6
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD 1.2 -19.7 19.6 92.4
KR
HLB Inc
KOSDAQ:028300
8.3T KRW 100 -36.7 -91.7 -86.8
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF 5.5 22.5 14.5 19.7
P/E Multiple
Earnings Growth PEG
CN
J
Jiangsu Nanfang Medical Co Ltd
SSE:603880
Average P/E: 31.8
Negative Multiple: -9.3
N/A N/A
JP
Hoya Corp
TSE:7741
40.9
13%
3.1
CH
Alcon AG
SIX:ALC
37.7
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.2
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
32
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.7
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.7 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
22.5
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
J
Jiangsu Nanfang Medical Co Ltd
SSE:603880
Average EV/EBITDA: 18.8
Negative Multiple: -12.3
N/A N/A
JP
Hoya Corp
TSE:7741
25.3
11%
2.3
CH
Alcon AG
SIX:ALC
19.7
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.3
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.5
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.9
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.6
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -91.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
14.5
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
J
Jiangsu Nanfang Medical Co Ltd
SSE:603880
Average EV/EBIT: 33.8
Negative Multiple: -12.3
N/A N/A
JP
Hoya Corp
TSE:7741
30.3
N/A N/A
CH
Alcon AG
SIX:ALC
38.4
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.2
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.4
16%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.6
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
92.4
60%
1.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -86.8 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
19.7
29%
0.7